Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead

Journal of Cardiovascular Electrophysiology

Volumn 21, Issue 6, 2010, Pages 671-677

  Ben Morrison, T ^a   Rea, Robert F ^a   Hodge, David O ^a   Crusan, Daniel ^a   Koestler, Celeste ^a   Asirvatham, Samuel J ^a   Bradley, David ^a   Shen, Win K ^a   Munger, Thomas M ^a   Hammill, Stephen C ^a   Friedman, Paul A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Fidelis lead; Implantable cardioverter defibrillator; Lead fracture; Syncope

Indexed keywords

LEAD;

ADULT; BIOLOGICAL MONITORING; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTHESIS FAILURE; RADIOGRAPHY; REVIEW; RISK FACTOR; ADOLESCENT; AGE; AGED; CHILD; DEVICE FAILURE; ELECTROCARDIOGRAPHY; ELECTRODE; FOLLOW UP; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; KAPLAN MEIER METHOD; MIDDLE AGED; MOTOR ACTIVITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SPORT; STATISTICAL ANALYSIS; SURVIVAL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; DATA INTERPRETATION, STATISTICAL; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; ELECTRODES; EQUIPMENT FAILURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOTOR ACTIVITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPORTS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 77952587743     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2009.01683.x     Document Type: Review

References (32)

1. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH, Defibrillators in Nonischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators : Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004 350 : 2151 2158.
2. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B : Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000 101 : 1297 1302.
3. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 1997 337 : 1576 1583.
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators : Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 : 225 237.
5. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM, Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators : Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004 350 : 2140 2150.
6. Maisel WH : Pacemaker and ICD generator reliability: Meta-analysis of device registries. JAMA 2006 295 : 1929 1934.
7. Maisel WH, Kramer DB : Implantable cardioverter-defibrillator lead performance. Circulation 2008 117 : 2721 2723.
8. Maisel WH : Transvenous implantable cardioverter-defibrillator leads: The weakest link. Circulation 2007 115 : 2461 2463.
9. Ellenbogen KA, Wood MA, Shepard RK, Clemo HF, Vaughn T, Holloman K, Dow M, Leffler J, Abeyratne A, Verness D : Detection and management of an implantable cardioverter defibrillator lead failure: Incidence and clinical implications. J Am Coll Cardiol 2003 41 : 73 80.
10. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K : Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 2007 115 : 2474 2480.
11. Dorwarth U, Frey B, Dugas M, Matis T, Fiek M, Schmoeckel M, Remp T, Durchlaub I, Gerth A, Steinbeck G, Hoffmann E : Transvenous defibrillation leads: High incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol 2003 14 : 38 43.
12. Hauser RG, Kallinen LM, Almquist AK, Gornick CC, Katsiyiannis WT : Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm 2007 4 : 892 896.
13. Groves R : Urgent Medical Device Information: Sprint Fidelis® Lead Patient Management Recommendations. 2007. Available at : http://www.medtronic. com/product-advisories/physician/Sprint-Fidelis®/PROD-ADV-PHYS-OCT.htm.
14. Sprint Fidelis® Model 6949 Lead Performance : May 2009 website update. Available at : http://www.medtronic.com/product-advisories/physician/ Sprint-Fidelis®/6949-LEAD-PERFORMANCE.htm. Accessed May 28, 2009.
15. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial II Investigators : Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346 : 877 883.
16. Swerdlow CD, Cannom DS : ICD product reliability: Lessons from electrical overstress failures. Pacing Clin Electrophysiol 2001 24 : 1043 1045.
17. Maloney JD, Hayes DL, Timmis GC : Report of the Policy Conference of NASPE on device/lead performance and the development of a postmarket surveillance database. The Writing Committee. Pacing Clin Electrophysiol 1993 16 : 1945 1952.
18. Farwell D, Green MS, Lemery R, Gollob MH, Birnie DH : Accelerating risk of Fidelis® lead fracture. Heart Rhythm 2008 5 : 1375 1379.
19. Carlson MD, Wilkoff BL, Maisel WH, Ellenbogen KA, Saxon LA, Prystowsky EN, Alpert JS, Cain ME, Ching EA, Curtis AB, Davies DW, Hammill SC, Hauser RG, Lampert R, Zipes DP, American College of Cardiology Foundation, American Heart Association; International Coalition of Pacing and Electrophysiology Organizations : Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacing and Electrophysiology Organizations (COPE). Heart Rhythm 2006 3 : 1250 1273.
20. Maisel WH, Hauser RG : Proceedings of the ICD Lead Performance Conference. Heart Rhythm 2008 5 : 1331 1338.
21. Hammill SC, Kremers MS, Stevenson LW, Kadish AH, Heidenreich PA, Lindsay BD, Mirro MJ, Radford MJ, Wang Y, Curtis JP, Lang CM, Harder JC, Brindis RG : Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm 2008 5 : 1359 1363.
22. Gallik DM, Ben-Zur UM, Gross JN, Furman S : Lead fracture in cephalic versus subclavian approach with transvenous implantable cardioverter defibrillator systems. Pacing Clin Electrophysiol 1996 19 : 1089 1094.
23. Parsonnet V, Roelke M : The cephalic vein cutdown versus subclavian puncture for pacemaker/ICD lead implantation. Pacing Clin Electrophysiol 1999 22 : 695 697.
24. Rao A, Wright J, Waktare J, Todd D : Sprint Fidelis® 6949 high-voltage lead appears to be prone to early failure. Heart Rhythm 2008 5 : 167.
25. Franklin WH, Perry JC, Dubin AM, Berul CI, on behalf of the Pediatric and Congenital Electrophysiology Society (PACES) : Fracture rate of a thin implantable cardioverter defibrillator lead is higher in pediatric and congential heart patients that in the general population. Heart Rhythm 2008 5 : 153 154.
26. October 2007 Physician Letter-Appendix B. http://www.medtronic.com/ product-advisories/physician/Sprint-Fidelis®/PROD-ADV-APP-B.htm. Accessed November 13, 2008.
27. Desai AS, Fang JC, Maisel WH, Baughman KL : Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: A meta-analysis of randomized controlled trials. JAMA 2004 292 : 2874 2879.
28. Korte T, Köditz H, Niehaus M, Paul T, Tebbenjohanns J : High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004 27 : 924 932.
29. Osorio H, Bhatia A, Pubbi D, Blanck Z, Dhala A, Sra J, Berger MG, Cooley R, Akhtar M : Biventricular implantable cardioverter-defibrillator in the elderly. Heart Rhythm 2005 2 : S98.
30. Panotopoulos PT, Axtell K, Anderson AJ, Sra J, Blanck Z, Deshpande S, Biehl M, Keelan ET, Jazayeri MR, Akhtar M, Dhala A : Efficacy of the implantable cardioverter-defibrillator in the elderly. J Am Coll Cardiol 1997 29 : 556 560.
31. Swerdlow CD, Gunderson BD, Ousdigian KT, Abeyratne A, Stadler RW, Gillberg JM, Patel AS, Ellenbogen KA : Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter- defibrillator leads. Circulation 2008 118 : 2122 2129.
32. Hauser RG, Hayes DL : Increasing hazard of Sprint Fidelis® implantable cardioverter-defibrillator lead failure. Heart Rhythm 2009 6 : 605 610.